The trial will be conducted on 100 patients at Al-Zahra and Kashani hospitals. In advance, the two drugs will be prepared by an emergency medicine specialist and will be identified in packages coded A and B so that the prescriber, as well as the clinical and baseline patient record holder, is not aware of the type of intervention. Fentanyl and ketamine are used as single doses, with doses of 1-2 µg / kg and 0.3 mg/kg, respectively. Ketamine 0.3 mg/kg will be diluted with 100 ml of normal saline and administered intravenously and slowly for 15 minutes. Demographic data, disease history, vital signs, type of limb fracture, pain score of patients prior to drug administration (at baseline), and at 15, 30 and 60 minutes after drug administration. Possible side effects such as nausea, vomiting, loss of consciousness, hypoxia, hypotension, etc. will be recorded.